203-142-3

应用筛选条件

关键词:'203-142-3'

显示 1-4 共 4 条结果关于 "203-142-3" 范围论文

Pediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs.

Adam M Zahm et al.

American journal of physiology. Gastrointestinal and liver physiology, 307(8), G803-G812 (2014-08-26)

The incidence of eosinophilic esophagitis (EoE) has increased in the past several years, yet our understanding of its pathogenesis remains limited. To test the hypothesis that microRNAs (miRNAs) are altered in children with EoE, miRNAs were profiled in esophageal mucosa

The protein phosphatases involved in cellular regulation. Primary structure of inhibitor-2 from rabbit skeletal muscle.

C F Holmes et al.

European journal of biochemistry, 155(1), 173-182 (1986-02-17)

The complete primary structure of inhibitor-2, a specific inhibitor of protein phosphatase-1, has been determined. The protein consists of a single polypeptide chain of 203 residues, and has a relative molecular mass of 22835 Da. This molecular mass is significantly

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

D H McDermott et al.

Circulation research, 89(5), 401-407 (2001-09-05)

Fractalkine, a chemokine expressed by inflamed endothelium, induces leukocyte adhesion and migration via the receptor CX3CR1, and the CX3CR1 polymorphism V249I affects receptor expression and function. Here we show that this polymorphism is an independent risk factor for atherosclerotic coronary

Thioridazine for schizophrenia.

M Fenton et al.

The Cochrane database of systematic reviews, (3)(3), CD001944-CD001944 (2007-07-20)

Thioridazine is an antipsychotic that can still be used for schizophrenia although it is associated with the cardiac arrhythmia, torsades de pointe. To review the effects of thioridazine for people with schizophrenia. For this 2006 update, we searched the Cochrane

1/1